HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Wellness Dietary Supplements Launches

UK Wellness Marketing News: Launches From P&G, Alliance And VÖOST

  • News

Executive Summary

The latest UK wellness marketing news, with three new omega-3 supplements from P&G, a chewable version of Alliance’s MacuShield eye supplement and a move into the fashionable “beauty from within” market from VÖOST.

You may also be interested in...



Clinova Helps Brits Keep Hydrated This Summer With New O.R.S. Additions

Keeping the UK hydrated is the focus of Clinova's new O.R.S. launches. The firm has also updated its Caidr self-care app to help people manage COVID-19-related health concerns and social distancing measures. 

UK’s Optibac Launches Pregnancy Probiotic

Optibac offers pregnant women in the UK a new science-backed probiotic supplement.

UK Marketing: Sanofi Launches Buscomint, New Releases From Salonpas and Nailner

The latest OTC launches in the UK, including Buscomint from Sanofi, Salonpas Gel-Patch from Hisamitsu and Nailner Active Cover from Karo.

Table

View full table

Related Content

HBW Insight

Topics

Tags:
Wellness Dietary Supplements Launches
Latest Headlines

Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States

Prestige Expands UK Eye Care Range In Response To Consumer Demand

Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation

Fenty Cleanser Performance Claims Supported, But Influencer Videos Need Disclaimers – NAD

See All
UsernamePublicRestriction

Register

RS150306

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By